Uncategorized - March 27, 2013
Oslo Cancer Cluster gets new Innovation Park
With construction starting in April 2013 the first tenants are expected to move in to the new Oslo Cancer Cluster Innovation Park in May 2015. The aim of Oslo Cancer Cluster Innovation Park AS is to reduce the development time for new medicines and diagnostics for cancer. Park will become the first to combine clinical […]
Profiles in Pharma - March 19, 2013
The global health pioneer
Dr. William Haseltine is specifically renowned for his pioneering work on cancer, HIV/AIDS and genomics. Through all of his undertakings, he has always kept the ultimate goal of curing the world’s populations from diseases in mind.
Science article - March 19, 2013
The quest for funding
Applying for grants is part of the everyday life of Swedish researchers. But the task can be a time consuming and difficult project when the competition is tough.
Acquisition - March 4, 2013
Radiometer Medical acquires HemoCue
Danish healthcare company Radiometer Medical recently announced the acquisition of Swedish diagnostics company HemoCue AB from Quest Diagnostics. The price for the deal is approximately 300 million USD, plus customary adjustments for cash balances.
Drug Development Pharma - March 4, 2013
75 staff members to leave APL
As Swedish contract manufacturer APL reforms the organization 75 staff members are being made redundant.
Drug Development Pharma - February 27, 2013
Diamyd’s shareholders in agreement
Shareholders in Diamyd Medical AB representing a majority of the votes in the company have reached an agreement to distribute the parent company’s excess cash to the shareholders and to convert all shares to series B shares with equal voting power. The shares in the subsidiary Diamyd Therapeutics AB shall be distributed to the shareholders […]
